News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2024
July 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
293031  
European Cancer Organisation – Sign up to the INTERACT- EUROPE 100 training
Photo taken from European Cancer Organisation/LinkedIn
Jul 3, 2024, 22:23

European Cancer Organisation – Sign up to the INTERACT- EUROPE 100 training

European Cancer Organisation shared on LinkedIn:

“Calling All Cancer Centres

Sign up to the INTERACTEUROPE100 training!

Apply now to be among the 100 cancer centres offering your professionals novel multidisciplinary training for the next three years.”.

Read further.
Source: European Cancer Organisation/LinkedIn

cancer European Cancer Organisation OncoDaily Oncology
Blog
Jul 5, 2024, 17:50
First-of-its-kind PhD program in cancer engineering - MSKCC
Blog
Jul 5, 2024, 17:27
Julie Ross shares the story of her career journey with OncoDaily - Advanced Clinical
Insight
Jul 5, 2024, 16:59
Pat Price: As we approach the general election, cancer must be a top priority for our new Government
Blog
Jul 5, 2024, 16:32
July edition of the IAPC's newsletter
Blog
Jul 5, 2024, 16:31
Fumiko Ladd Chino: I strongly support Dr Neha Vapiwala for President at ASTRO
Insight
Jul 5, 2024, 16:30
CAR NK cells with CD28 costimulation improved cell persistence and antitumor activity
Blog
Jul 5, 2024, 16:21
Latest episodes from the Precision Medicine podcast
Insight
Jul 5, 2024, 16:12
Sunscreen Is Your Best Friend This Summer - Sylvester Cancer Experts
Drugs
Jul 5, 2024, 15:53
Gevorg Tamamyan: Waiting too see promising bot/bal results from our lung cancer trial
Insight
Jul 5, 2024, 15:41
Development of an EORTC QoL module for patients with advanced melanoma
Blog
Jul 5, 2024, 15:32
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Drugs
Jul 5, 2024, 15:03
Andrea Apolo: Phase 1 study of Cabozantinib, Nivolumab, and Ipilimumab for genitourinary tumours